CELESTICA INC (CLS)

Celestica shares surged 5.23% to close at $300.06, with the stock trading between $283.11 and $308.21 on volume of over 5.2 million shares. The rally followed a wave of bullish analyst actions, as Citigroup maintained its Buy rating and raised its price target to $436, UBS set a new $453 target, and Barclays kept its Overweight rating while lifting its target to $414. These upgrades suggest growing confidence in Celestica's outlook and likely fueled today's positive price action. The direction signal is clearly bullish given the cluster of raised targets.

Celestica shares fell 7.77% to close at $246.25 despite reporting third-quarter adjusted earnings of $3.30 per share and revenue of $5.830 billion, both beating Wall Street targets. The company also raised its FY2026 adjusted EPS outlook to $11.55 and revenue view to $21.0 billion, and issued a strong FY2027 guidance of $21.50 per share and $40.0 billion in sales, both above analyst estimates. However, its fourth-quarter outlook of $3.37-$3.57 adjusted per-share profit and $6.275-$6.575 billion in revenue came in near or slightly below consensus, likely disappointing investors and driving the stock lower. The mixed signals—strong long-term guidance but a softer near-term forecast—resulted in a sharp sell-off, with the stock closing near its daily low of $246.24.